Bringing 3D-Printed Medical Devices To Market In An Uncertain Regulatory Environment
More than 80 3D-printed medical devices have been brought to market in the United States to date, and that number stands to grow rapidly, as demand for personalized medicine increases. Yet, the premarket regulatory pathway for 3D-printed devices remains unclear. In this podcast, regulatory strategy expert Michael Drues looks to shed some light on this ambiguity and provide practical advice to help device makers get their 3D-printed technology to market.
This website uses cookies to ensure you get the best experience on our website. Learn more